Pharma's Big Role in Cardio-Oncology

Episode 25

Orginally Published:

August, 16 2022

Episode Description

The Leaders of the IC-OS Pharmacy Working Group, Heather N. Moore (PharmD, BCOP, CPP, Clinical Oncology Pharmacist, Breast Oncology, Duke University Medical Center) and Craig Beavers (PharmD, Assistant Professor of Pharmacy Science at the University of Kentucky), discuss the pharmacist's role in caring for cardio-oncology patients and how to implement their assistance in cardio-oncology treatment based on their experience in this scenario.

1. Bringing the pharmacist to the cardio-oncology team makes a more substantial work group to ensure the best assistance to our patients.

2. Having the pharmacist in the working group participating actively in the clinical decisions and helping plan the patient’s next steps can improve tolerance to the treatment, fewer side effects from the drug, and fewer worst interactions between the chronic medications and the oncologic treatment based on the drug profile of each patient.

3. Improving treatment maintenance with the presence of a pharmacist specialized in cardio-oncology, with early recognition of cardiotoxicity and how to modify the therapy to ensure the best treatment, either changing the time of infusion or route of administration, or physical formulation

4. Stimulating new research about new oncology therapies to understand better drug profiles, side effects, pharmacodynamics, and medication interactions.

Supplementary material

Yaseen I, Farhan H, et al. INTERVENTIONS BY THE CARDIOLOGY CLINICAL PHARMACIST AT THE CARDIO-ONCOLOGY CLINIC. J Am Coll Cardiol. 2022 Mar, 79 (9_Supplement) 2186. https://doi.org/10.1016/S0735-1097(22)03177-1

Yaseen IF and Farhan HA (2022) Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study. Front. Cardiovasc. Med. 9:972455. doi: 10.3389/fcvm.2022.972455

Campia U, Moslehi J, Amiri-Kordestani L, Et. Al. Cardio-Oncology: Vascular And Metabolic Perspectives A Scientific Statement From The American Heart Association. Circulation. 2019;139:E579–E602

Armenian SH, Lacchetti C, Barac A, Et Al. Prevention And Monitoring Of Cardiac Dysfunction In Survivors Of Adult Cancers: American Society Of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2017;35:893-911

Show Notes Provided by:

Alana de Quadros Schroeder, MDHospital Cardiologist Hospital Moinhos de Vento Cardiology Department